Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction
Background Persistent airflow obstruction (PAO) in patients with asthma can be difficult to treat. Tezepelumab blocks thymic stromal lymphopoietin, an epithelial cytokine implicated in asthma pathogenesis. This analysis evaluated the efficacy of tezepelumab in patients with severe, uncontrolled asth...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
European Respiratory Society
2024-11-01
|
| Collection: | ERJ Open Research |
| Accès en ligne: | http://openres.ersjournals.com/content/10/6/00164-2024.full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|